PEPTIDE CORTEXThe library
← The library

5-Amino-1MQ

not a peptideNot a peptide · small moleculeMetabolic/Weight
Evidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
0
Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeMetabolic / Weight
MechanismSmall-molecule NNMT inhibitor; included here because it is used alongside metabolic peptides
EffectsStudied for fat-cell metabolism in preclinical models; no human trials
DosingNo human dose established.
Bottom linePopular in research/compounding; human safety/benefit not well-established.
Protocols · as published1 sourced
Community protocol — not clinically establishedCommunity guide
RouteOral capsule mainly; subcutaneous secondarily
FrequencyOnce daily
Starting50 mg oral once daily, weeks 1-2. SC: 2.5 mg daily on days 1-2, then 5 mg.
Escalation100 mg oral daily from week 3; 150 mg is the upper option
Target50-150 mg/day oral; 2.5-5 mg/day SC
Cycle8 to 12 weeks on, then 4 to 6 weeks off

The guide itself says "No human trial has established a typical 5-Amino-1MQ dose." Figures are extrapolated from mice. Not a peptide.

Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Not FDA-approved; avoid self-administration; unverified sourcing and purity

No well-established interaction profile for non-approved peptides; avoid combining multiple research compounds; discuss meds with clinician.

CV 0 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.